WALDENCAST ACQUISITION CORP

NASDAQ: WALD (Waldencast plc)

Kemas kini terakhir: 18 Feb, 1:11PM

1.77

-0.05 (-2.75%)

Penutupan Terdahulu 1.82
Buka 1.80
Jumlah Dagangan 21,163
Purata Dagangan (3B) 102,216
Modal Pasaran 219,402,464
Harga / Jualan (P/S) 0.660
Harga / Buku (P/B) 0.400
Julat 52 Minggu
1.45 (-18%) — 3.54 (100%)
Tarikh Pendapatan 17 Mar 2026
Margin Keuntungan -15.50%
Margin Operasi (TTM) -18.31%
EPS Cair (TTM) -0.390
Pertumbuhan Hasil Suku Tahunan (YOY) 30.80%
Jumlah Hutang/Ekuiti (D/E MRQ) 24.95%
Nisbah Semasa (MRQ) 1.35
Aliran Tunai Operasi (OCF TTM) -8.82 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 8.34 M
Pulangan Atas Aset (ROA TTM) -3.32%
Pulangan Atas Ekuiti (ROE TTM) -6.49%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Household & Personal Products (US) Bercampur Menurun
Household & Personal Products (Global) Bercampur Menurun
Stok Waldencast plc Menurun Menurun

AISkor Stockmoo

-0.8
Konsensus Penganalisis -0.5
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal -0.5
Purata -0.75

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
WALD 219 M - - 0.400
NWL 2 B 5.96% - 0.770
HELE 420 M - - 0.480
EWCZ 313 M - 22.00 2.16
UG 33 M 6.86% 16.95 2.87
DSY 16 M - - 462.91

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Sektor Consumer Defensive
Industri Household & Personal Products
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 56.95%
% Dimiliki oleh Institusi 25.62%

Pemilikan

Nama Tarikh Syer Dipegang
Zeno Equity Partners Llp 31 Dec 2025 12,252,580
Milestones Administradora De Recursos Ltda. 31 Dec 2025 2,425,677
Julat 52 Minggu
1.45 (-18%) — 3.54 (100%)
Median 2.00 (12.99%)
Jumlah 1 Beli
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Jefferies 14 Jan 2026 2.00 (12.99%) Beli 1.63

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
06 Feb 2026 Pengumuman Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
05 Feb 2026 Pengumuman Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
03 Feb 2026 Pengumuman Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
30 Jan 2026 Pengumuman Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
28 Jan 2026 Pengumuman Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
27 Jan 2026 Pengumuman UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
27 Jan 2026 Pengumuman Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
26 Jan 2026 Pengumuman CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
26 Jan 2026 Pengumuman Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
21 Jan 2026 Pengumuman Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda